Steven Cohen Boston Scientific Corp Call Options Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $2.31 Million - $2.65 Million	31,600 Added 118.35%	58,300 $4.89 Million
Q2 2024 Aug 14, 2024	BUY	$67.33 - $77.71 $949,353 - $1.1 Million	14,100 Added 111.9%	26,700 $2.06 Million
Q1 2024 May 15, 2024	BUY	$57.6 - $68.62 $725,760 - $864,612	12,600 New	12,600 $862,000
Q2 2023 Aug 14, 2023	BUY	$49.72 - $54.64 $1.13 Million - $1.24 Million	22,700 New	22,700 $1.23 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $567,364 - $758,310	16,100 New	16,100 $600,000

1,542

1.19B

6.79M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $127B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.